Merck KGaA: stock down after Q3 results
(CercleFinance.com) - Merck KGaA shares are down over 2% in Frankfurt, despite the publication of EPS adjusted for exceptional items that is up 11.
1% at E2.30, and adjusted EBITDA up 11.9% to E1.62bn, for Q3 2024.
Its corresponding margin improved by 2.8 points to 30.7% on sales of almost E5.23bn, up 1.8% (+3.8% organic) thanks to positive performances in all three sectors.
The German group reports a return to organic sales growth in Life Sciences, solid sales growth and outstanding profitability in Health Care, as well as another quarter of profitable growth in Electronics.
Merck KGaA confirms its FY targets, stating that it is heading towards the middle of its target ranges for adjusted EPS (E8.20 to E9.30) and EBITDA (E5.8bn to E6.4bn), but in the lower half of that for sales (E20.7bn to E22.1bn).
Copyright (c) 2024 CercleFinance.com. All rights reserved.
1% at E2.30, and adjusted EBITDA up 11.9% to E1.62bn, for Q3 2024.
Its corresponding margin improved by 2.8 points to 30.7% on sales of almost E5.23bn, up 1.8% (+3.8% organic) thanks to positive performances in all three sectors.
The German group reports a return to organic sales growth in Life Sciences, solid sales growth and outstanding profitability in Health Care, as well as another quarter of profitable growth in Electronics.
Merck KGaA confirms its FY targets, stating that it is heading towards the middle of its target ranges for adjusted EPS (E8.20 to E9.30) and EBITDA (E5.8bn to E6.4bn), but in the lower half of that for sales (E20.7bn to E22.1bn).
Copyright (c) 2024 CercleFinance.com. All rights reserved.